Rosa Impact Webinar Announcement

Learnings from the Field: The Rosa Physiological Model Qualification Method by Dr. Christina Friedrich Chief Engineer Rosa & Co LLC April 24, 2013 1:00 to 2:00 pm EDT >From Dr. Friedrich, "Mechanistic physiological or systems pharmacology modeling is employed by pharmaceutical companies to support decisions at every step of the drug development pipeline. Use of a quality standard such as the Model Qualification Method (MQM) is necessary to ensure impact and support the broad-scale adoption of this technology. Rosa has used the MQM in modeling projects in many disease areas ranging from early discovery to phase2 and 3 clinical work. With its continued application, it has become clear that principled use of the MQM keeps modeling projects focused, captures key model assumptions and insights, facilitates the conversation between modelers and scientists, and provides a useful mechanism for ensuring that such models are fit for purpose. In this webinar, we will review the principles of the MQM and highlight learnings from the field." The purpose of the "Impact" series is to foster the use of M&S activities in all phases of drug development by illustrating the advantages and enhancing the applicability of M&S in product discovery, development, and marketing programs. The series is intended for drug development project team members from discovery to phase 4 clinical trials. This includes pharmacologists, ADME scientists, PK/PD modelers, clinical pharmacologists, clinical development team members, regulatory affairs specialists, and other interested professionals. Register for this free webinar at www.rosaandco.com/webinar. After registering you will receive a confirmation email containing information about joining the webinar. More information about the webinar series, an archive of past webinars, and a list of future webinar speakers may be found at www.rosaandco.com/webinar. Please allow 5-10 minutes for a Java applet to be installed on your computer prior to joining our webinar series for the first time. Toufigh Gordi Toufigh Gordi, PhD President, PK/PD and Clinical Pharmacology Services Direct: 408-480-7314 Corp: 408-370-9800 Fax: 408-370-9810 [email protected]